Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR–ABL-positive acute lymphoblastic leukemia

Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993

(2009) Adele K. Fielding et al.   BLOOD

Impact of tyrosine kinase inhibitors on patient outcomes in Philadelphia chromosome-positive acute lymphoblastic leukaemia

(2009) Franz Gruber et al.   BRITISH JOURNAL OF HAEMATOLOGY

First-line treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia in adults

(2009) Oliver G Ottmann et al.   CURRENT OPINION IN ONCOLOGY

Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 trial

(2009) J.-M. Ribera et al.   HAEMATOLOGICA

Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimen

(2008) G. G. Laport et al.   BLOOD

The Japan Marrow Donor Program, the Japan Cord Blood Bank Network and the Asia Blood and Marrow Transplant Registry

(2008) Y Kodera   BONE MARROW TRANSPLANTATION

Treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia

(2008) Ryuzo Ohno   Current Oncology Reports